Cytogenetics of solid tumors

The Principles of Clinical Cytogenetics

Volumn , Issue , 2005, Pages 421-451

  Fletcher, Jonathan A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920063591     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1385/1-59259-833-1:421     Document Type: Chapter

References (198)

1. Sreekantaiah, C., Appaji, L., and Hazarika, D. (1992) Cytogenetic characterisation of small round cell tumours using fine needle aspiration. J. Clin. Pathol. 45, 728-730.
2. Akerman, M., Dreinhofer, K., Rydholm, A., et al. (1996) Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing's sarcoma. Diagn. Cytopathol. 15, 17-22.
3. Hoffer, F. A., Gianturco, L. E., Fletcher, J. A., and Grier, H. E. (1994) Percutaneous biopsy of peripheral primitive neuroectodermal tumors and Ewing's sarcomas for cytogenetic analysis. Am. J. Roentgenol. 162, 1141-1142.
4. Saboorian, M. H., Ashfaq, R., Vandersteenhoven, J. J., and Schneider, N. R. (1997) Cytogenetics as an adjunct in establishing a definitive diagnosis of synovial sarcoma by fine-needle aspiration. Cancer 81, 187-192.
5. Cajulis, R. S. and Frias-Hidvegi, D. (1993) Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Acta Cytol. 37, 391-396.
6. Cajulis, R. S., Kotliar, S., Haines, G. K., Frias-Hidvegi, D., and O'Gorman, M. (1994) Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn. Cytopathol. 11, 151-158.
7. Limon, J., Dal Cin, P., and Sandberg, A. A. (1986) Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet. Cytogenet. 23, 305-313.
8. Ried, T. (1998) Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am. J. Pathol. 152, 325-327.
9. Hsi, B. L., Xiao, S., and Fletcher, J. A. (2002) Chromogenic in situ hybridization and FISH in pathology. Methods Mol. Biol. 204, 343-351.
10. Hopman, A. H., Claessen, S., and Speel, E. J. (1997) Multi-colour brightfield in situ hybridisation on tissue sections. Histochem. Cell Biol. 108, 291-298.
11. Speel, E. J., Ramaekers, F. C., and Hopman, A. H. (1995) Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, "who is still afraid of red, green and blue?" J. Histochem. 27, 833-858.
12. Liu, E., Thor, A., He, M., Barcos, M., Ljung, B. M., and Benz, C. (1992) The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7, 1027-1032.
13. Ross, J. S., Fletcher, J. A., Linette, G. P., et al. (2003) The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 8, 307-325.
14. Kim, S. Y., Lee, J. S., Ro, J. Y., Gay, M. L., Hong, W. K., and Hittelman, W. N. (1993) Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity. Am. J. Pathol. 142, 307-317.
15. Schofield, D. E. and Fletcher, J. A. (1992) Trisomy 12 in pediatric granulosa-stromal cell tumors. Demonstration by a modified method of fluorescence in situ hybridization on paraffin-embedded material. Am. J. Pathol. 141, 1265-1269.
16. Paternoster, S. F., Brockman, S. R., McClure, R. F., Remstein, E. D., Kurtin, P. J., and Dewald, G. W. (2002) A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am. J. Pathol. 160, 1967-1972.
17. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821.
18. Albertson, D. G., Ylstra, B., Segraves, R., et al. (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25, 144-146.
19. Schrock, E., Du Manoir, S., Veldman, T., Nat. Genet. (1996) Multicolor spectral karyotyping of human chromosomes. Science 273, 494-497.
20. Veldman, T., Vignon, C., Schrock, E., Rowley, J. D., and Ried, T. (1997) Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nature Genet. 15, 406-410.
21. Macville, M., Schrock, E., Padilla-Nash, H., Nat. Genet. (1999) Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 59, 141-150.
22. Mackall, C. L., Meltzer, P. S., and Helman, L. J. (2002) Focus on sarcomas. Cancer Cell 2, 175-178.
23. Oliveira, A. M. and Fletcher, J. A. (2002) Translocation breakpoints in cancer. In Encyclopedia of the Human Genome Nature. Publishing, London, U. K.
24. Look, A. T., Hayes, F. A., Shuster, J. J., et al. (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J. Clin. Oncol. 9, 581-591.
25. Delattre, O., Zucman, J., Plougastel, B., et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.
26. Turc-Carel, C., Philip, I., Berger, M. P., Philip, T., and Lenoir, G. M. (1984) Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t (11;22) (q24;q12). Cancer Genet. Cytogenet. 12, 1-19.
27. Turc-Carel, C., Aurias, A., Mugneret, F., et al. (1988) Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t (11;22) (q24;q12). Cancer Genet. Cytogenet. 32, 229-238.
28. Ewen, M. E., Ludlow, J. W., Marsilio, E., et al. (1989) An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 58, 257-267.
29. Buckler, A. J., Chang, D. D., Graw, S. L., et al. (1991) Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc. Natl. Acad. Sci. USA 88, 4005-4009.
30. Jeon, I. S., Davis, J. N., Braun, B. S., et al. (1995) A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229-1234.
31. Peter, M., Couturier, J., Pacquement, H., et al. (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159-1164.
32. Kaneko, Y., Yoshida, K., Handa, M., et al. (1996) Fusion of an ETS-family gene, EIAF, to EWS by t (17;22) (q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 15, 115-121.
33. Ishida, S., Yoshida, K., Kaneko, Y., et al. (1998). The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma. Cytogenet. Cell Genet. 82, 278-283.
34. Desmaze, C., Zucman, J., Delattre, O., Melot, T., Thomas, G., and Aurias, A. (1994) Interphase molecular cytogenetics of Ewing's sarcoma and peripheral neuroepithelioma t (11;22) with flanking and overlapping cosmid probes. Cancer Genet. Cytogenet. 74, 13-18.
35. Barr, F. G., Chatten, J., D'Cruz, C. M., et al. (1995) Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273, 553-557.
36. Zoubek, A., Dockhorn-Dworniczak, B., Delattre, O., et al. (1996) Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245-1251.
37. De Alava, E., Kawai, A., Healey, J. H., et al. (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 16, 1248-1255.
38. Fletcher, J. A. (1998) Ewing's sarcoma oncogene structure: a novel prognostic marker? J. Clin. Oncol. 16, 1241-1243.
39. Davison, J. M., Morgan, T. W., Hsi, B. L., Xiao, S., and Fletcher, J. A. (1998) Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications. Am. J. Pathol. 153, 1401-1409.
40. Galili, N., Davis, R. J., Fredericks, W. J., et al. (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet. 5, 230-235.
41. Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., and Emanuel, B. S. (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet. 3, 113-117.
42. Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., and Naeve, C. W. (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-5112.
43. Davis, R. J., D'Cruz, C. M., Lovell, M. A., Biegel, J. A., and Barr, F. G. (1994) Fusion of PAX7 to FKHR by the variant t (1;13) (p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869-2872.
44. Davis, R. J., and Barr, F. G. (1997) Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 94, 8047-8051.
45. Fredericks, W. J., Galili, N., Mukhopadhyay, S., et al. (1995) The PAX3-FKHR fusion protein created by the t (2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell Biol. 15, 1522-1535.
46. Bennicelli, J. L., Fredericks, W. J., Wilson, R. B., Rauscher, F. J.3rd, and Barr, F. G. (1995) Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11, 119-130.
47. Turc-Carel, C., Dal Cin, P., Limon, J., et al. (1987) Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc. Natl. Acad. Sci. USA 84, 1981-1985.
48. Limon, J., Mrozek, K., Mandahl, N., et al. (1991) Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3, 338-345.
49. Clark, J., Rocques, P. J., Crew, A. J., et al. (1994) Identification of novel genes, SYT and SSX, involved in the t (X;18) (p11.2;q11.2) translocation found in human synovial sarcoma. Nature Genet. 7, 502-508.
50. Janz, M., De Leeuw, B., Weghuis, D. O., et al. (1995) Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J. Pathol. 175, 391-396.
51. Shipley, J. M., Clark, J., Crew, A. J., et al. (1994) The t (X;18) (p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 9, 1447-1453.
52. Kawai, A., Woodruff, J., Healey, J. H., Brennan, M. F., Antonescu, C. R., and Ladanyi, M. (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med. 338, 153-160.
53. Sreekantaiah, C., Leong, S. P., Karakousis, C. P., et al. (1991) Cytogenetic profile of 109 lipomas. Cancer Res. 51, 422-433.
54. Mandahl, N., Hoglund, M., Mertens, F., et al. (1994) Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9, 207-215.
55. Fletcher, C. D., Akerman, M., Dal Cin, P., et al. (1996) Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am. J. Pathol. 148, 623-630.
56. Ashar, H. R., Fejzo, M. S., Tkachenko, A., et al. (1995) Disruption of the architectural factor HMGI-C: DNA-binding A-T hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82, 57-65.
57. Mandahl, N., Mertens, F., Willen, H., Rydholm, A., Brosjo, O., and Mitelman, F. (1994) A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas. J. Cancer Res. Clin. Oncol. 120, 707-711.
58. Hibbard, M. K., Kozakewich, H. P., Dal Cin, P., et al. (2000) PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 60, 4869-4872.
59. Mrozek, K., Karakousis, C. P., and Bloomfield, C. D. Band 11q13 is nonrandomly rearranged in hibernomas. (1994) Genes Chromosomes Cancer 9, 145-147.
60. Turc-Carel, C., Limon, J., Dal Cin, P., Rao, U., Karakousis, C., and Sandberg, A. A. (1986) Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t (12;16) (q13;p11) in myxoid liposarcomas. Cancer Genet. Cytogenet. 23, 291-299.
61. Sreekantaiah, C., Karakousis, C. P., Leong, S. P., and Sandberg, A. A. (1992) Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 69, 2484-2495.
62. Hisaoka, M., Tsuji, S., Morimitsu, Y., et al. (1998) Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn. Mol. Pathol. 7, 96-101.
63. Kuroda, M., Ishida, T., Horiuchi, H., et al. (1995) Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am. J. Pathol. 147, 1221-1227.
64. Aman, P., Ron, D., Mandahl, N., et al. (1992) Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t (12;16) (q13;p11). Genes Chromosomes Cancer 5, 278-285.
65. Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644.
66. Mandahl, N., Heim, S., Arheden, K., Rydholm, A., Willen, H., and Mitelman, F. (1988) Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet. Cytogenet. 30, 23-33.
67. Turc-Carel, C., Dal Cin, P., Rao, U., Karakousis, C., and Sandberg, A. A. (1988) Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet. Cytogenet. 30, 145-150.
68. Pedeutour, F., Forus, A., Coindre, J. M., et al. (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24, 30-41.
69. Zucman, J., Delattre, O., Desmaze, C., et al. (1993) EWS and ATF-1 gene fusion induced by t (12;22) translocation in malignant melanoma of soft parts. Nature Genet. 4, 341-345.
70. Brown, A. D., Lopez-Terrada, D., Denny, C., and Lee, K. A. (1995) Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. Oncogene 10, 1749-1756.
71. Gerald, W. L., Miller, H. K., Battifora, H., Miettinen, M., Silva, E. G., and Rosai, J. (1991) Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am. J. Surg. Pathol. 15, 499-513.
72. Ladanyi, M. and Gerald, W. (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54, 2837-2840.
73. Gerald, W. L., Ladanyi, M., De Alava, E., et al. (1998) Clinical, pathologic, and molecular spectrum of tumors associated with t (11;22) (p13;q12): desmoplastic small round-cell tumor and its variants. J. Clin. Oncol. 16, 3028-3036.
74. Rodriguez, E., Sreekantaiah, C., Gerald, W., Reuter, V. E., Motzer, R. J., and Chaganti, R. S. (1993) recurring translocation, t (11;22) (p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet. Cytogenet. 69, 17-21.
75. Biegel, J. A., Conard, K., and Brooks, J. J. (1993) Translocation (11;22) (p13;q12): primary change in intra-abdominal desmoplastic small round cell tumor. Genes Chromosomes Cancer 7, 119-121.
76. Lee, S. B., Kolquist, K. A., Nichols, K., et al. (1997) The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nature Genet. 17, 309-313.
77. Kelly, J. D., Haldeman, B. A., Grant, F. J., et al. (1991) Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem. 266, 8987-8992.
78. Pedeutour, F., Simon, M. P., Minoletti, F., et al. (1995) Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res. 55, 2400-2403.
79. Naeem, R., Lux, M. L., Huang, S. F., Naber, S. P., Corson, J. M., and Fletcher, J. A. (1995) Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am. J. Pathol. 147, 1553-1558.
80. Simon, M. P., Pedeutour, F., Sirvent, N., et al. (1997) Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nature Genet. 15, 95-98.
81. O'Brien, K. P., Seroussi, E., Dal Cin, P., et al. (1998) Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23, 187-193.
82. Maki, R. G., Awan, R. A., Dixon, R. H., Jhanwar, S., and Antonescu, C. R. (2002) Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer 100, 623-626.
83. Rubin, B. P., Schuetze, S. M., Eary, J. F., et al. (2002) Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 20, 3586-3591.
84. Alman, B. A., Li, C., Pajerski, M. E., Diaz-Cano, S., and Wolfe, H. J. (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am. J. Pathol. 151, 329-334.
85. Tejpar, S., Nollet, F., Li, C., et al. (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18, 6615-6620.
86. Fletcher, J. A., Naeem, R., Xiao, S., and Corson, J. M. (1995) Chromosome aberrations in desmoid tumors. Trisomy 8 might be a predictor of recurrence. Cancer Genet. Cytogenet. 79, 139-143.
87. Miyaki, M., Konishi, M., Kikuchi-Yanoshita, R., et al. (1993) Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 53, 5079-5082.
88. Sen-Gupta, S., Van Der Luijt, R. B., Bowles, L. V., Meera Khan, P., and Delhanty, J. D. (1993) Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis. Lancet 342, 552-553.
89. Schofield, D. E., Fletcher, J. A., Grier, H. E., and Yunis, E. J. (1994) Fibrosarcoma in infants and children. Application of new techniques. Am. J. Surg. Pathol. 18, 14-24.
90. Schofield, D. E., Yunis, E. J., and Fletcher, J. A. (1993) Chromosome aberrations in mesoblastic nephroma. Am. J. Pathol. 143, 714-724.
91. Knezevich, S. R., McFadden, D. E., Tao, W., Lim, J. F. and Sorensen, P. H. (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genet. 18, 184-187.
92. Rubin, B. P., Chen, C. J., Morgan, T. W., et al. (1998) Congenital mesoblastic nephroma t (12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am. J. Pathol. 153, 1451-1458.
93. Knezevich, S. R., Garnett, M. J., Pysher, T. J., Beckwith, J. B., Grundy, P. E., and Sorensen, P. H. (1998) ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 58, 5046-5048.
94. Treissman, S. P., Gillis, D. A., Lee, C. L., Giacomantonio, M., and Resch, L. (1994) Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer 73, 1433-1437.
95. Snyder, C. S., Dell'Aquila, M., Haghighi, P., Baergen, R. N., Suh, Y. K., and Yi, E. S. (1995) Clonal changes in inflammatory pseudotumor of the lung: a case report. Cancer 76, 1545-1549.
96. Su, L. D., Atayde-Perez, A., Sheldon, S., Fletcher, J. A., and Weiss, S. W. (1998) Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod. Pathol. 11, 364-368.
97. Lawrence, B., Perez-Atayde, A., Hibbard, M. K., et al. (2000) TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 157, 377-384.
98. Hirota, S., Isozaki, K., Moriyama, Y., et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580.
99. Rubin, B. P., Singer, S., Tsao, C., et al. (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61, 8118-8121.
100. Heinrich, M. C., Corless, C. L., Duensing, A., et al. (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708-710.
101. Demetri, G. D., Von Mehren, M., Blanke, C. D., et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472-480.
102. Van Oosterom, A. T., Judson, I., Verweij, J., et al. (2001) Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358, 1421-1423.
103. Nishida, T., Hirota, S., Taniguchi, M., et al. (1998) Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nature Genet. 19, 323-324.
104. Sarlomo-Rikala, M., El-Rifai, W., Lahtinen, T., Andersson, L. C., Miettinen, M., and Knuutila, S. (1998) Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum. Pathol. 29, 476-481.
105. El Rifai, W., Sarlomo-Rikala, M., Andersson, L. C., Knuutila, S., and Miettinen, M. (2000) DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 60, 3899-3903.
106. Schneider-Stock, R., Boltze, C., Lasota, J., et al. (2003) High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J. Clin. Oncol. 21, 1688-1697.
107. Legius, E., Marchuk, D. A., Collins, F. S., and Glover, T. W. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet. 3, 122-126.
108. Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., and Downward, J. (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713-715.
109. De Clue, J. E., Papageorge, A. G., Fletcher, J. A., et al. (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265-273.
110. Rouleau, G. A., Merel, P., Lutchman, M., et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363, 515-521.
111. Twist, E. C., Ruttledge, M. H., Rousseau, M., et al. (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum. Mol. Genet. 3, 147-151.
112. Lutchman, M. and Rouleau, G. A. (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res. 55, 2270-2274.
113. Kluwe, L., Friedrich, R., and Mautner, V.-F. (1999) Loss of NF1 allele in Schwann cells but not in fibroblasts dervied from an NF1-associated neurofibroma. Genes Chromosomes Cancer 24, 283-285.
114. Murthy, S. S. and Testa, J. R. (1999) Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell Physiol. 180, 150-157.
115. Lechner, J. F., Tokiwa, T., La Veck, M., et al. (1985) Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl. Acad. Sci. USA 82, 3884-3888.
116. Ault, J. G., Cole, R. W., Jensen, C. G., Jensen, L. C. W., Bachert, L. A., and Rieder, C. L. (1995) Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res. 55, 792-798.
117. Hayashi, Y., Inaba, T., Hanada, R., and Yamamoto, K. (1988) Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J. Pediatr. 112, 567-571.
118. Brodeur, G. M., Azar, C., Brother, M., et al. (1992) Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 70, 1685-1694.
119. Shapiro, D. N., Valentine, M. B., Rowe, S. T., et al. (1993) Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am. J. Pathol. 142, 1339-1346.
120. Komuro, H., Valentine, M. B., Rowe, S. T., et al. (1998) Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. J. Pediatr. Surg. 33, 1695-1698.
121. Versteege, I., Sevenet, N., Lange, J., et al. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203-206.
122. Biegel, J. A., Zhou, J. Y., Rorke, L. B., Stenstrom, C., Wainwright, L. M., and Fogelgren, B. (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74-79.
123. Sevenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R., and Delattre, O. (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 65, 1342-1348.
124. Roberts, C. W., Galusha, S. A., McMenamin, M. E., Fletcher, C. D., and Orkin, S. H. (2000) Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl. Acad. Sci. USA 97, 13, 796-13, 800.
125. Sreekantaiah, C., Davis, J. R., and Sandberg, A. A. (1993) Chromosomal abnormalities in leiomyosarcomas. Am. J. Pathol. 142, 293-305.
126. Mitelman, F. (1998) Catalog of Chromosome Aberrations in Cancer 1998, 6th ed. Wiley-Liss, New York
127. Fletcher, J. A., Morton, C. C., Pavelka, K., and Lage, J. M. (1990) Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res. 50, 4092-4097.
128. Nibert, M. and Heim, S. (1990) Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2, 3-13.
129. Nilbert, M., Heim, S., Mandahl, N., Floderus, U. M., Willen, H., and Mitelman, F. (1990) Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet. Cytogenet. 45, 63-66.
130. Xing, Y. P., Powell, W. L., and Morton, C. C. (1997) The del (7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet. Cytogenet. 98, 69-74.
131. Schoenmakers, E. F., Huysmans, C., and Van De Ven, W. J. (1999) Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t (12;14) uterine leiomyomas. Cancer Res. 59, 19-23.
132. Kovacs, G. and Frisch, S. (1989) Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res. 49, 651-659.
133. Yamakawa, K., Morita, R., Takahashi, E., Hori, T., Ishikawa, J., and Nakamura, Y. (1991) A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res. 51, 4707-4711.
134. Presti, J. C., Jr., Rao, P. H., Chen, Q., et al. (1991) Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 51, 1544-1552.
135. Kovacs, G. (1989) Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am. J. Pathol. 134, 27-34.
136. Kaneko, Y., Homma, C., Maseki, N., Sakurai, M., and Hata, J. (1991) Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res. 51, 5937-5942.
137. Grundy, P. E., Telzerow, P. E., Breslow, N., Moksness, J., Huff, V., and Paterson, M. C. (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res. 54, 2331-2333.
138. Fromowitz, F. B. and Bard, R. H. (1980) Clinical implications of pathologic subtypes in renal cell carcinoma. Semin. Urol. 8, 31-50.
139. Presti, J. C., Jr., Reuter, V. E., Cordon-Cardo, C., Mazumdar, M., Fair, W. R., and Jhanwar, S. C. (1993) Allelic deletions in renal tumors: histopathological correlations. Cancer Res. 53, 5780-5783.
140. Latif, F., Tory, K., Gnarra, J., et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317-1320.
141. Whaley, J. M., Naglich, J., Gelbert, L., et al. (1994) Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092-1102.
142. Shuin, T., Kondo, K., Torigoe, S., et al. (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54, 2852-2855.
143. Ohta, M., Inoue, H., Cotticelli, M. G., et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597.
144. La Forgia, S., Lasota, J., Latif, F., et al. (1993) Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t (3;8) (p14.2;q24.1). Cancer Res. 53, 3118-3124.
145. Limon, J., Mrozek, K., Heim, S., et al. (1990) On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma. Cancer Genet. Cytogenet. 49, 259-263.
146. Emanuel, A., Szucs, S., Weier, H. U., and Kovacs, G. (1992) Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer 4, 75-77.
147. Dal Cin, P., Aly, M. S., Delabie, J., et al. (1992) Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc. Natl. Acad. Sci. USA 89, 9744-9748.
148. Crotty, T. B., Farrow, G. M., and Lieber, M. M. (1995) Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J. Urol. 154, 964-967.
149. Speicher, M. R., Schoell, B., Du Manoir, S., et al. (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 145, 356-364.
150. Kovacs, G., Fuzesi, L., Emanual, A., and Kung, H. F. (1991) Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3, 249-255.
151. Renshaw, A. A., Zhang, H., Corless, C. L., Fletcher, J. A., and Pins, M. R. (1997) Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am. J. Surg. Pathol. 21, 1203-1209.
152. Brown, J. A., Anderl, K. L., Borell, T. J., Qian, J., Bostwick, D. G., and Jenkins, R. B. (1997) Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J. Urol. 158, 370-374.
153. Kovacs, G. (1993) Molecular differential pathology of renal cell tumours. Histopathology 22, 1-8.
154. Mancilla-Jimenez, R., Stanley, R. J., and Blath, R. A. (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38, 2469-2480.
155. Corless, C. L., Aburatani, H., Fletcher, J. A., Housman, D. E., Amin, M. B., and Weinberg, D. S. (1996) Papillary renal cell carcinoma: Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn. Mol. Pathol. 5(1), 53-64.
156. Corless, C. L., Aburatani, H., Fletcher, J. A., Housman, D. E., Amin, M. B., and Weinberg, D. S. (1996) Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn. Mol. Pathol. 5, 53-64.
157. Meloni, A. M., Dobbs, R. M., Pontes, J. E., and Sandberg, A. A. (1993) Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet. Cytogenet. 65, 1-6.
158. Argani, P., Antonescu, C. R., Illei, P. B., et al. (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 159, 179-192.
159. Davis, I. J., Hsi, B. L., Arroyo, J. D., et al. (2003) Cloning of an alpha-TFEB fusion in renal tumors harboring the t (6;11) (p21;q13) chromosome translocation. Proc. Natl. Acad. Sci. USA 100, 6051-6056.
160. Brown, J. A., Takahashi, S., Alcaraz, A., et al. (1996) Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J. Urol. 156, 31-35.
161. Van Den Berg, E., Dijkhuizen, T., Storkel, S., et al. (1995) Chromosomal changes in renal oncocytomas. Evidence that t (5;11) (q35;q13) might characterize a second subgroup of oncocytomas. Cancer Genet. Cytogenet. 79, 164-168.
162. Fuzesi, L., Gunawan, B., Braun, S., and Boeckmann, W. (1994) Renal oncocytoma with a translocation t (9;11) (p23;q13). J. Urol. 152, 471-472.
163. Crotty, T. B., Lawrence, K. M., Moertel, C. A. A., et al. (1992) Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 might be a characteristic anomaly in renal oncocytomas. Cancer Genet. Cytogenet. 61, 61-66.
164. Meloni, A. M., Sandberg, A. A., and White, R. D. (1992)-Y, -1 as recurrent anomaly in oncocytoma. Cancer Genet. Cytogenet. 61, 108-109.
165. Weremowicz, S., Kozakewich, H. P., Haber, D., Park, S., Morton, C. C., and Fletcher, J. A. (1994) Identification of genetically aberrant cell lineages in Wilms' tumors. Genes Chromosomes Cancer 10, 40-48.
166. Solis, V., Pritchard, J., and Cowell, J. K. (1988) Cytogenetic changes in Wilms' tumors. Cancer Genet. Cytogenet. 34, 223-234.
167. Slater, R. M. and Mannens, M. M. (1992) Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet. Cytogenet. 61, 111-121.
168. Haber, D. A., Buckler, A. J., Glaser, T., et al. (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61, 1257-1269.
169. Bruening, W., Bardeesy, N., Silverman, B. L., et al. (1992) Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet. 1, 144-148.
170. Ton, C. C., Hirvonen, H., Miwa, H., et al. (1991) Positional cloning and characterization of a paired box- and homeoboxcontaining gene from the aniridia region. Cell 67, 1059-1074.
171. Douglass, E. C., Look, A. T., Webber, B., Parham, D., Wilimas, J. A., Green, A. A., and Roberson, P. K. (1986) Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor. J. Clin. Oncol. 4, 975-981.
172. Bardeesy, N., Falkoff, D., Petruzzi, M. J., et al. (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet. 7, 91-97.
173. Bolande, R. P., Brough, A. J., and Izant, R. J. Jr. (1967) Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics 40, 272-278.
174. Pettinato, G., Manivel, J. C., Wick, M. R., and Dehner, L P. (1989) Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum. Pathol. 20, 682-690.
175. Mascarello, J. T., Cajulis, T. R., Krous, H. F., and Carpenter, P. M. (1994) Presence or absence of trisomy 11 is correlated with histologic subtype in congenital mesoblastic nephroma. Cancer Genet. Cytogenet. 77, 50-54.
176. Wang, S., Saboorian, M. H., Frenkel, E., Hynan, L., Gokaslan, S. T., and Ashfaq, R. (2000) Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays. J. Clin. Pathol. 53, 374-381.
177. Tanner, M., Gancberg, D., Di Leo, A., et al. (2000) Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am. J. Pathol. 157, 1467-1472.
178. Zhao, J., Wu, R., Au, A., Marquez, A., Yu, Y., and Shi, Z. (2002) Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod. Pathol. 15, 657-665.
179. Vocke, C. D., Pozzatti, R. O., Bostwick, D. G., et al. (1996) Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res. 56, 2411-2416.
180. Huang, S. F., Xiao, S., Renshaw, A. A., Loughlin, K. R., Hudson, T. J., and Fletcher, J. A. (1996) Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am. J. Pathol. 149, 1565-1573.
181. Cher, M. L., Ito, T., Weidner, N., Carroll, P. R., and Jensen, R. H. (1995) Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J. Urol. 153, 249-254.
182. Gray, I. C., Phillips, S. M., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., and Spurr, N. K. (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55, 4800-4803.
183. Matsuyama, H., Pan, Y., Oba, K., et al. (2003) The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer. Aktuelle Urol. 34, 247-249.
184. Matsuyama, H., Pan, Y., Yoshihiro, S., et al. (2003) Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer. Prostate 54, 103-111.
185. Nemoto, R., Nakamura, I., Uchida, K., and Harada, M. (1995) Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Br. J. Urol. 75, 470-476.
186. Stadler, W. M., Sherman, J., Bohlander, S. K., et al. (1994) Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res. 54, 2060-2063.
187. Sandberg, A. A. and Berger, C. S. (1994) Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J. Urol. 151, 545-560.
188. Skacel, M., Fahmy, M., Brainard, J. A., et al. (2003) Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J. Urol. 169, 2101-2105.
189. Stadler, W. M., Steinberg, G., Yang, X., Hagos, F., Turner, C., and Olopade, O. I. (2001) Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin. Cancer Res. 7, 1676-1682.
190. Anonymous (1988) Occupational bladder cancer: a guide for clinicians. The BAUS Subcommittee on Industrial Bladder Cancer. Br. J. Urol. 61, 183-191.
191. Schulte, P. A., Ringen, K., Hemstreet, G. P., et al. (1986) Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer 58, 2156-2162.
192. Hartge, P., Hoover, R., and Kantor, A. (1985) Bladder cancer risk and pipes, cigars, and smokeless tobacco. Cancer 55, 901-906.
193. El-Bolkainy, M. N., Mokhtar, N. M., Ghoneim, M. A., and Hussein, M. H. (1981) The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 48, 2643-2648.
194. Reifenberger, G. and Louis, D. N. (2003) Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J. Neuropathol. Exp. Neurol. 62, 111-126.
195. Ino, Y., Betensky, R. A., Zlatescu, M. C., et al. (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7, 839-845.
196. Eller, J. L., Longo, S. L., Hicklin, D. J., and Canute, G. W. (2002) Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Neurosurgery 51, 1005-1013.
197. Bosl, G. J., Ilson, D. H., Rodriguez, E., Motzer, R. J., Reuter, V. E., and Chaganti, R. S. (1994) Clinical relevance of the i (12p) marker chromosome in germ cell tumors. J. Natl. Cancer Inst. 86, 349-355.
198. Mertens, F., Johansson, B., and Mitelman, F. (1994) Isochromosomes in neoplasia. Genes Chromosomes Cancer 10, 221-230.